The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol Myers Squibb, citing the suspicious timing of their 340B rebate proposals.
AHA accuses drug companies of colluding to impose 340B rebate plans